Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene

被引:77
作者
Innocenti, Federico [1 ,3 ,4 ]
Liu, Wanqing [1 ]
Fackenthal, Donna [2 ]
Ramirez, Jacqueline [1 ]
Chen, PeiXian [2 ]
Ye, Xin [1 ]
Wu, Xiaolin [2 ]
Zhang, Wei [1 ]
Mirkov, Snezana [1 ]
Das, Soma [2 ,3 ]
Cook, Edwin, Jr. [5 ]
Ratain, Mark J. [1 ,3 ,4 ]
机构
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Genet, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Clin Pharmacol & Pharmacogenom, Chicago, IL 60637 USA
[4] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
[5] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
关键词
haplotype; pharmacogenetics; single nucleotide polymorphism; splicing variant; UDP-glucuronosyltransferase; 2B7;
D O I
10.1097/FPC.0b013e3283037fe4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective UDP-glucuronosyltransferase 2B7 (UGT2B7) plays a central role in the liver-mediated biotransformation of endogenous and exogenous compounds. The genetic basis of interindividual variability in UGT2B7 function is unknown. This study aimed to discover novel gene variants of functional significance. Methods Caucasian human livers n=54) were used. UGT2B7 was resequenced in 12 samples [(six highest and six lowest for the formation of morphine-3-glucuronide (M3G)]. Haplotype-tagging single nucleotide polymorphisms were genotyped in the entire sample set. Samples were phenotyped for mRNA expression. Results 10 haplotype-tagging single nucleotide polymorphisms were identified and their haplotypes were inferred. Haplotype 4 (-45597G; -6682-6683A; 372A; IVS1 + 9_IVS1 + 10A; IVS1 + 829T; IVS1 + 985G; lVS1 + 999C; IVS1 + 1250G; 801 T; IVS4 + 185C) (frequency of 0.12) was associated with an increase in enzyme activity and gene expression. The 1/4 and 4/6 diplotypes had higher M3G formation compared with 1/1 (P<0.05) and 2/3 (P<0.01) diplotypes. Diplotypes containing haplotype 4 resulted in a significant 45% average increase in the formation of M3G compared with diplotypes without haplotype 4 (P=0.002). There was also an association between haplotype 4 and increased mRNA expression. lVS1 +985A>G, 735A>G, and 1062C>T are the putative functional variants of haplotype 4. We also identified two mRNA splicing variants (UGT2B7_v2 and UGT2B7_v3) splicing out exon 1, 4, 5, and 6 but sharing exons 2 and 3 with the involvement of additional 5' exons. UGT2B7_v2 was detected in all livers tested, but UGT2B7_v3 was present at much lower levels compared with UGT2B7_v2. The UGT2B7 reference sequence mRNA is now named UGT2B7_v. Conclusion UGT2B7 haplotype 4 is functional and its effects on the biotransformation of UGT2B7 substrates should be tested in controlled clinical trials. Biochemical studies should investigate the functional role of the newly discovered mRNA splicing variants.
引用
收藏
页码:683 / 697
页数:15
相关论文
共 30 条
[1]   Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance [J].
Bhasker, CR ;
McKinnon, W ;
Stone, A ;
Lo, ACT ;
Kubota, T ;
Ishizaki, T ;
Miners, JO .
PHARMACOGENETICS, 2000, 10 (08) :679-685
[2]   Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium [J].
Carlson, CS ;
Eberle, MA ;
Rieder, MJ ;
Yi, Q ;
Kruglyak, L ;
Nickerson, DA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (01) :106-120
[3]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[4]  
Coffman BL, 1998, DRUG METAB DISPOS, V26, P73
[5]   Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy [J].
Coffman, BL ;
Kearney, WR ;
Green, MD ;
Lowery, RG ;
Tephly, TR .
MOLECULAR PHARMACOLOGY, 2001, 59 (06) :1464-1469
[6]   Environmental and genetic factors associated with morphine response in the postoperative period [J].
Coulbault, L ;
Beaussier, M ;
Verstuyft, C ;
Weickmans, H ;
Dubert, L ;
Trégouet, D ;
Descot, C ;
Parc, Y ;
Lienhart, A ;
Jaillon, P ;
Becquemont, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) :316-324
[7]   UGT2B7 promoter variant-840G&gt;A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease [J].
Darbari, Deepika S. ;
van Schalk, Ron H. N. ;
Capparelli, Edmund V. ;
Rana, Sohail ;
McCarter, Robert ;
van den Anker, John .
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (03) :200-202
[8]   A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity [J].
Duguay, Y ;
Báár, C ;
Skorpen, F ;
Guillemette, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) :223-233
[9]   Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene:: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients [J].
Holthe, M ;
Rakvåg, TN ;
Klepstad, P ;
Idle, JR ;
Kaasa, S ;
Krokan, HE ;
Skorpen, F .
PHARMACOGENOMICS JOURNAL, 2003, 3 (01) :17-26
[10]   Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes [J].
Ikushiro, S ;
Emi, Y ;
Iyanagi, T .
BIOCHEMISTRY, 1997, 36 (23) :7154-7161